Immunoengineering Ucd Freeman Lab

Ucd Freeman Lab Our lab is interested in understanding the role of the sting pathway in how the innate immune system recognizes osteosarcoma. this understanding would enable us to develop a therapeutic that targets this pathway, enhancing the therapeutic potential of chemotherapy and preventing chemoresistance. Recently, we have cloned two novel members of the b7 gene family, which bind to receptors expressed on activated t cells and further regulate the development of an immune response. current studies focus on the function of these novel b7 genes and their interactions with the b7 cd28 ctla 4 pathway.

Ucd Freeman Lab The freeman lab aims to investigate the use of innovative engineering techniques to better understand and develop novel therapeutics for treating damaged and diseased bone tissue. Our lab has developed a multicellular 3d spheroid model of osteosarcoma which can model early and late stage osteosarcoma. our lab is now interested in increasing the complexity of this model through the incorporation of immune cells. Dr. freeman leads a multidisciplinary research group investigating the use of innovative biomedical engineering techniques to better understand and develop novel therapeutics to treat paediatric bone cancer, osteosarcoma. 🚨 exciting opportunity! 🚨 the freeman lab is #hiring a fully funded (european research council (erc)) phd student to develop a cutting edge lung metastasis on a chip model for osteosarcoma.

Ucd Freeman Lab Dr. freeman leads a multidisciplinary research group investigating the use of innovative biomedical engineering techniques to better understand and develop novel therapeutics to treat paediatric bone cancer, osteosarcoma. 🚨 exciting opportunity! 🚨 the freeman lab is #hiring a fully funded (european research council (erc)) phd student to develop a cutting edge lung metastasis on a chip model for osteosarcoma. The freeman lab aims to investigate the use of innovative engineering techniques to better understand and develop novel therapeutics for treating damaged and diseased bone tissue. Dr. víctor burgueño sandoval is a postdoctoral researcher in the freeman lab at university college dublin (ucd). he earned his degree in chemistry in 2018 and his phd cum laude in 2024 from the university of barcelona, spain. This is a fantastic chance to join my team at ucd mechanical and materials engineering and ucd conway institute to advance cancer research using innovative bioengineering techniques. Our lab aims to use these advanced models not only to gain a better understanding of osteosarcoma tumour biology and behaviour but also to serve as invaluable platforms for drug testing, personalized medicine, and the exploration of novel therapeutic strategies.

Ucd Freeman Lab The freeman lab aims to investigate the use of innovative engineering techniques to better understand and develop novel therapeutics for treating damaged and diseased bone tissue. Dr. víctor burgueño sandoval is a postdoctoral researcher in the freeman lab at university college dublin (ucd). he earned his degree in chemistry in 2018 and his phd cum laude in 2024 from the university of barcelona, spain. This is a fantastic chance to join my team at ucd mechanical and materials engineering and ucd conway institute to advance cancer research using innovative bioengineering techniques. Our lab aims to use these advanced models not only to gain a better understanding of osteosarcoma tumour biology and behaviour but also to serve as invaluable platforms for drug testing, personalized medicine, and the exploration of novel therapeutic strategies.